相关实验视频
Updated: Sep 10, 2025

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
乌帕达西提尼单一疗法用于治疗白皮病
Mohamad R Taha1, Harrison P Nguyen2, Stephen K Tyring2,3
1College of Medicine, Texas A&M University Health Science Center, Bryan, Texas.
皮肤 (PG) 是一种痛苦的皮肤. 这项研究显示,upadacitinib是一种Janus激酶 (JAK) 抑制剂,成功治疗了PG患者,为患者提供了新的治疗选择.
科学领域:
- 皮肤病学
- 免疫学
- 药理学
背景情况:
- 皮肤炎 (PG) 是一种罕见的性中性病皮肤病.
- 目前的治疗方法缺乏标准化,
- 雅努斯酶 (JAK) /信号转换器和转录激活器 (STAT) 途径与PG病变有关.
研究的目的:
- 评估选择性JAK抑制剂upadacitinib在治疗白皮病时的疗效.
主要方法:
- 这项研究描述了一系列患有白皮病的患者.
- 患者接受了选择性Janus激酶抑制剂 (JAK) 的治疗.
主要成果:
- 在此系列病例中,upadacitinib 已成功治愈了皮肤.
- 这种治疗使得渐进而痛苦的愈了.
结论:
- 使用upadacitinib进行选择性JAK抑制是一种有前途的治疗方法.
- 针对JAK/STAT途径为这种情况提供了潜在的治疗策略.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Ulcerative Colitis in IBD
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Acute Pyelonephritis II: Diagnostic Studies and Management
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

